Last reviewed · How we verify

Carboxymethylcellulose sodium and Glycerin

Allergan · FDA-approved active Small molecule Quality 6/100

Carboxymethylcellulose sodium and Glycerin is a Non-Standardized Chemical Allergen [EPC] Small molecule drug developed by Allergan. It is currently FDA-approved.

At a glance

Generic nameCarboxymethylcellulose sodium and Glycerin
SponsorAllergan
Drug classNon-Standardized Chemical Allergen [EPC]
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Carboxymethylcellulose sodium and Glycerin

What is Carboxymethylcellulose sodium and Glycerin?

Carboxymethylcellulose sodium and Glycerin is a Non-Standardized Chemical Allergen [EPC] drug developed by Allergan.

Who makes Carboxymethylcellulose sodium and Glycerin?

Carboxymethylcellulose sodium and Glycerin is developed and marketed by Allergan (see full Allergan pipeline at /company/allergan).

What drug class is Carboxymethylcellulose sodium and Glycerin in?

Carboxymethylcellulose sodium and Glycerin belongs to the Non-Standardized Chemical Allergen [EPC] class. See all Non-Standardized Chemical Allergen [EPC] drugs at /class/non-standardized-chemical-allergen-epc.

What development phase is Carboxymethylcellulose sodium and Glycerin in?

Carboxymethylcellulose sodium and Glycerin is FDA-approved (marketed).

Related